Cargando…

Gene Therapy in Rare Respiratory Diseases: What Have We Learned So Far?

Gene therapy is an alternative therapy in many respiratory diseases with genetic origin and currently without curative treatment. After five decades of progress, many different vectors and gene editing tools for genetic engineering are now available. However, we are still a long way from achieving a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bañuls, Lucía, Pellicer, Daniel, Castillo, Silvia, Navarro-García, María Mercedes, Magallón, María, González, Cruz, Dasí, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463867/ https://www.ncbi.nlm.nih.gov/pubmed/32784514 http://dx.doi.org/10.3390/jcm9082577

Ejemplares similares

Special Issue: Rare Respiratory Diseases: A Personal and Public Health Issue
por: Magallón, María, et al.
Publicado: (2021)

Oxidative Stress and Endoplasmic Reticulum Stress in Rare Respiratory Diseases
por: Magallón, María, et al.
Publicado: (2021)

Correction: Magallon et al. Oxidative Stress and Endoplasmic Reticulum Stress in Rare Respiratory Diseases. J. Clin. Med. 2021, 10, 1268
por: Magallón, María, et al.
Publicado: (2022)

Pediatric Myocarditis: What Have We Learnt So Far?
por: Pomiato, Elettra, et al.
Publicado: (2022)

Hypoxia Enhances Oxidative Stress in Neutrophils from ZZ Alpha-1 Antitrypsin Deficiency Patients
por: Magallón, María, et al.
Publicado: (2023)

COVID-19: What We Have Learned So Far
por: Clifford, Theresa
Publicado: (2020)

Sarcopenia in chronic kidney disease: what have we learned so far?
por: Sabatino, Alice, et al.
Publicado: (2020)

The hypocretins and the reward function: what have we learned so far?
por: Boutrel, Benjamin, et al.
Publicado: (2013)

Brain Tumor Immunotherapy: What have We Learned so Far?
por: Van Gool, Stefaan Willy
Publicado: (2015)

Editorial: Cancer Nanotheranostics: What Have We Learned So Far?
por: Conde, João, et al.
Publicado: (2016)

OMICs in Cariology and Endodontology – what have we learned so far?
por: Zaura, Egija
Publicado: (2017)

Circadian Clocks in Fish—What Have We Learned so far?
por: Frøland Steindal, Inga A., et al.
Publicado: (2019)

Offline: COVID-19—what have we learned so far?
por: Horton, Richard
Publicado: (2020)

What have we learnt so far from COVID-19?
por: Doherty, Peter C.
Publicado: (2021)

Bleeding in COVID Patients: What We Have Understood So Far
por: Lucatelli, Pierleone, et al.
Publicado: (2021)

Ovarian Cancer Radiosensitivity: What Have We Understood So Far?
por: Barcellini, Amelia, et al.
Publicado: (2022)

ECMO Retrieval Program: What Have We Learned So Far
por: Krasivskyi, Ihor, et al.
Publicado: (2023)

COVID-19 and the heart: what we have learnt so far
por: Shaha, Kunal Bikram, et al.
Publicado: (2020)

What we know so far
Publicado: (2021)

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

Campylobacter Phage Isolation and Characterization: What We Have Learned So Far
por: Jäckel, Claudia, et al.
Publicado: (2019)

Editorial: Cancer Epidemiology in China: What We Have Learnt So Far?
por: Chen, Tianhui, et al.
Publicado: (2020)

MRD Tailored Therapy in AML: What We Have Learned So Far
por: Ngai, Lok Lam, et al.
Publicado: (2021)

New Laboratory Protocol to Determine the Oxidative Stress Profile of Human Nasal Epithelial Cells Using Flow Cytometry
por: Reula, Ana, et al.
Publicado: (2021)

Anabaenopeptins: What We Know So Far
por: Monteiro, Patrick Romano, et al.
Publicado: (2021)

Erratum to: Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

Esophageal Mucosal Resistance in Reflux Esophagitis: What We Have Learned So Far and What Remains to Be Learned
por: Maev, Igor V., et al.
Publicado: (2023)

Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
por: Alkilany, Alaaldin M., et al.
Publicado: (2010)

Neural synchrony within the motor system: what have we learned so far?
por: van Wijk, Bernadette C. M., et al.
Publicado: (2012)

NEO adjuvant chemotherapy in breast cancer: What have we learned so far?
por: Raut, Nirmal V, et al.
Publicado: (2010)

Combining inclusive and exclusive data analyses-what have we learned so far?
por: Kittel, E W
Publicado: (1973)

Theory: Historical perspective and what have we learned from the Higgs so far
por: Ellis, Jonathan R.
Publicado: (2022)

Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far
por: Pacitti, Dario, et al.
Publicado: (2018)

The COVID-19 Pandemic and Cardiovascular Complications: What Have We Learned So Far?
por: Walsh, Mary Norine, et al.
Publicado: (2020)

More on the MORE Life Experience Model: What We Have Learned (So Far)
por: Glück, Judith, et al.
Publicado: (2018)

Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
por: Fukui, Hiroshi
Publicado: (2019)

Proteomics of Rice—Magnaporthe oryzae Interaction: What Have We Learned So Far?
por: Meng, Qingfeng, et al.
Publicado: (2019)

Implementation of the Nagoya Protocol in Livestock Sector: What Have We Learnt So Far?
por: Martyniuk, Elzbieta, et al.
Publicado: (2021)

Feline Morbillivirus Infection in Domestic Cats: What Have We Learned So Far?
por: De Luca, Eliana, et al.
Publicado: (2021)

Twenty years of mini-laparoscopy in Brazil: What we have learned so far
por: Lima, Diego Laurentino, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qk5kltkbqqqg984iggthprea97